Prosecution Insights
Last updated: August 18, 2026

Examiner: VU, JAKE MINH

Tech Center 1600 • Art Units: 1614 1618

This examiner grants 41% of resolved cases

Performance Statistics

40.7%
Allow Rate
-19.3% vs TC avg
845
Total Applications
+27.6%
Interview Lift
1520
Avg Prosecution Days
Based on 801 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
20.9%
§102 Novelty
41.3%
§103 Obviousness
22.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18267136 INSTANTLY GELLING COMPOSITIONS FOR ARTIFICIAL SALIVA AND ULTRASOUND GELS Non-Final OA KONINKLIJKE PHILIPS N.V.
18248191 METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER Non-Final OA WASHINGTON UNIVERSITY
18556703 PHOSPHINATE ESTER-CONTAINING DYES HAVING TUNABLE PROPERTIES AND METHODS OF MAKING THE SAME Non-Final OA NUTECH VENTURES
17293663 COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER Non-Final OA Actinium Pharmaceuticals, Inc.
18219656 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Final Rejection MICROVASCULAR THERAPEUTICS, LLC
17616166 COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES Non-Final OA MICROVASCULAR THERAPEUTICS, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month